The USA Patient Network

More than 1 million reports of drug side effects were filed with the U.S. Food and Drug Administration in 2015, a fivefold increase since 20

The Senate will soon begin the process of considering President Trump’s nomination of Dr. Scott Gottlieb, who has close professional and fin

Power morcellators likely contributed to injury and deaths of hundreds of women, according to a new study by the Government Accountability O

Robert Comis describes the success of the NCI-MATCH trial and involving patient advocates in the process.

The USA Patient Network outlines the risks of supporting the Right to Try Act and asks senators to withdraw their support.

Read why President Trump's plan to streamline the FDA approval process will make patients less safe and will cause their health to suffe

The USA Patient Network thanks senators for not co-sponsoring the Trickett Wendler Right to Try Act because it would put patients in harm’s

Read what happened when one doctor took the time to sit back and let their patients talk about their health uninterrupted.

President Diana Zuckerman is cited in an article that discusses the effectiveness of recently approved oncology drugs that seem to offer lit

In a meeting with top pharmaceutical executives, President Trump offers no specific policies but emphasizes the need for lowering drug price

President Trump promised some of the nation’s top drug company executives in a meeting at the White House on Tuesday that he would slash reg

Most health insurance companies also treated individual patients with pre-existing conditions differently than those that bought health insu

As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he

A new analysis finds longer regulatory review times for high-risk cardiovascular medical devices to be associated with fewer adverse event r

The evidence supporting Exondys 51, an FDA approved drug meant to treat Duchenne muscular dystrophy, is too thin for a drug that costs $300,

The Food and Drug Administration's approval process is confusing, complicated and intertwined with lobbyists and top drug company execut

Our comments are focused on the issues of inclusion and barriers to participation, but also on the broader issue of making sure that patient

Doctors often prescribe drugs "off label", meaning for purposes it wasn't approved for by the FDA. Most don't tell their p

The USA Patient Network respectfully and strongly urges senators to vote against the 21st Century Cures Act this week, and instead insist th

In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies sho